Quantifying the incidence of clinically significant respiratory depression in women with and without obesity class III receiving neuraxial morphine for post-cesarean analgesia: a retrospective cohort study
- PMID: 34053816
- PMCID: PMC8314929
- DOI: 10.1016/j.ijoa.2021.103187
Quantifying the incidence of clinically significant respiratory depression in women with and without obesity class III receiving neuraxial morphine for post-cesarean analgesia: a retrospective cohort study
Abstract
Background: Obesity is a suspected risk factor for respiratory depression following neuraxial morphine for post-cesarean analgesia, however monitoring guidelines for obese obstetric patients are based on small, limited studies. We tested the hypothesis that clinically significant respiratory depression following neuraxial morphine occurs more commonly in women with body mass index (BMI) ≥40 kg/m2 compared with BMI <40 kg/m2.
Methods: We conducted a single-center, retrospective chart review (2006-2017) of obstetric patients with clinically significant respiratory depression following neuraxial morphine, defined as: (1) opioid antagonist administration; (2) rapid response team activation (initiated in April 2010); or (3) tracheal intubation due to a respiratory event. The incidence of respiratory depression was compared between women with BMI ≥40 kg/m2 and BMI <40 kg/m2.
Results: In total, 11 327 women received neuraxial morphine (n=1945 BMI ≥40 kg/m2; n=9382 BMI <40 kg/m2). Women with BMI ≥40 kg/m2 had higher rates of sleep apnea, hypertensive disorders, and magnesium administration. Sixteen cases of clinically significant respiratory depression occurred within seven days postpartum. The incidence did not significantly differ between groups (odds ratio 2.2, 95% CI 0.6 to 6.9, P=0.174). Neuraxial morphine was not deemed causative in any case, however women with BMI ≥40 kg/m2 had higher rates of tracheal intubation unrelated to neuraxial morphine (2/1945 vs. 0/9382, P=0.029).
Conclusions: Respiratory depression in this population is rare. A larger sample (∼75 000) is required to determine whether the incidence is higher with BMI ≥40 kg/m2. Tracheal intubation was higher among the BMI ≥40 kg/m2 cohort, likely due to more comorbidities.
Keywords: Cesarean delivery; Neuraxial morphine; Obesity; Respiratory depression; Respiratory monitoring.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
A retrospective assessment of the incidence of respiratory depression after neuraxial morphine administration for postcesarean delivery analgesia.Anesth Analg. 2013 Dec;117(6):1368-70. doi: 10.1213/ANE.0b013e3182a9b042. Anesth Analg. 2013. PMID: 24257387
-
Respiratory depression after administration of single-dose neuraxial morphine for post-cesarean delivery analgesia: a retrospective cohort study.Int J Obstet Anesth. 2022 Nov;52:103592. doi: 10.1016/j.ijoa.2022.103592. Epub 2022 Aug 24. Int J Obstet Anesth. 2022. PMID: 36137450
-
Society for Obstetric Anesthesia and Perinatology Consensus Statement: Monitoring Recommendations for Prevention and Detection of Respiratory Depression Associated With Administration of Neuraxial Morphine for Cesarean Delivery Analgesia.Anesth Analg. 2019 Aug;129(2):458-474. doi: 10.1213/ANE.0000000000004195. Anesth Analg. 2019. PMID: 31082964
-
Incidence of respiratory depression after epidural administration of morphine for cesarean delivery: findings using a continuous respiratory rate monitoring system.Int J Obstet Anesth. 2019 May;38:32-36. doi: 10.1016/j.ijoa.2018.10.009. Epub 2018 Oct 26. Int J Obstet Anesth. 2019. PMID: 30477999
-
A Systematic Review Evaluating Neuraxial Morphine and Diamorphine-Associated Respiratory Depression After Cesarean Delivery.Anesth Analg. 2018 Dec;127(6):1385-1395. doi: 10.1213/ANE.0000000000003636. Anesth Analg. 2018. PMID: 30004934
Cited by
-
Analgesia after cesarean section - what is new?Curr Opin Anaesthesiol. 2023 Jun 1;36(3):288-292. doi: 10.1097/ACO.0000000000001259. Epub 2023 Mar 1. Curr Opin Anaesthesiol. 2023. PMID: 36994740 Free PMC article. Review.
-
Obstructive sleep apnea in pregnant women.Int Anesthesiol Clin. 2022 Apr 1;60(2):59-65. doi: 10.1097/AIA.0000000000000360. Int Anesthesiol Clin. 2022. PMID: 35261345 Free PMC article.
-
The use of intrathecal morphine for acute postoperative pain in lower limb arthroplasty surgery: a survey of practice at an academic hospital.J Orthop Surg Res. 2022 Jun 21;17(1):323. doi: 10.1186/s13018-022-03215-0. J Orthop Surg Res. 2022. PMID: 35729586 Free PMC article.
References
-
- Ko S, Goldstein DH, VanDenKerkhof EG. Definitions of “respiratory depression” with intrathecal morphine postoperative analgesia: A review of the literature Définitions de la “dépression respiratoire” de l’analgésie postopératoire réalisée avec de la morphine intrathécale : une revue documentaire. Can J Anaesth. 2003;50:679–688. 10.1007/BF03018710. - DOI - PubMed
-
- Abouleish E, Rawal N, Rashad MN. The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery: A prospective study of 856 cases. Reg Anesth.. 1991;16:137–140. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous